| Literature DB >> 29615070 |
Robinson Ramírez-Vélez1, María Correa-Rodríguez2, Alejandra Tordecilla-Sanders3, Viviana Aya-Aldana3, Mikel Izquierdo4, Jorge Enrique Correa-Bautista3, Cristian Álvarez5,6, Antonio Garcia-Hermoso7.
Abstract
BACKGROUND: There is evidence to suggest that postprandial lipemia are is linked to the impairment of endothelial function, which is characterized by an imbalance between the actions of vasodilators and vasoconstrictors. The aim of this study was to determine the effects of a 12-week high-intensity training (HIT) and moderate continuous training (MCT) protocol on postprandial lipemia, vascular function and arterial stiffness in inactive adults after high-fat meal (HFM) ingestion.Entities:
Keywords: Endothelial function; Exercise intensity; High-intensity exercise; Moderate continuous training; Postprandial lipemia
Mesh:
Substances:
Year: 2018 PMID: 29615070 PMCID: PMC5883528 DOI: 10.1186/s12944-018-0719-3
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Fig. 1Schedule of experimental events for each subject. HIT, high-intensity interval training; MCT, moderate-intensity continuous training; HFM, high-fat meal. Discontinuous arrows represent capillary blood samples and assessment of endothelial function
Demographic, biochemical and endothelial function variables in the fasted state across HIT and MCT groups at baseline
| Characteristics | HIT ( | MCT ( | |
|---|---|---|---|
| Sex, n (%) | |||
| Male | 8 (40.0) | 5 (55.6) | 0.898 |
| Female | 3 (60.0) | 4 (44.4) | 0.916 |
| Age, mean (sd), y | 31.8 (7.8) | 31.4 (6.4) | 0.928 |
| Biochemical parameters, mean (SD) | |||
| Total cholesterol (mg/dL) | 159.4 (47.4) | 170.1 (41.8) | 0.301 |
| High-density lipoprotein (mg/dL) | 46.9 (9.6) | 43.0 (14.1) | 0.236 |
| Triglycerides (mg/dL) | 100.4 (36.8) | 134.1 (82.2) | 0.118 |
| Glucose (mg/dL) | 78.3 (5.6) | 82.3 (13.7) | 0.190 |
| Vascular function parameters, mean (SD) | |||
| Dbase, mm | 3.0 (0.6) | 2.7 (0.4) | 0.157 |
| FMD, % | 7.2 (3.3) | 7.3 (5.6) | 0.487 |
| | 3.2 (0.5) | 3.0 (0.5) | 0.140 |
| | 0.2 (0.5) | 0.3 (0.4) | 0.496 |
| FMDn, % | 6.5 (2.9) | 7.4 (5.7) | 0.433 |
| PWV, m·s−1 | 6.7 (0.8) | 7.1 (1.2) | 0.204 |
| AIx (aortic), % | 41.7 (10.4) | 24.5 (32.7) | 0.148 |
| AIx (brachial), % | 16.5 (5.2) | 25.1 (16.5) | 0.152 |
| Pulse Pressure (mmHg) | 45.3 (5.2) | 44.6 (4.1) | 0.931 |
| Central systolic blood pressure (mmHg) | 99.6 (43.7) | 108.0 (5.8) | 0.493 |
| Pulmonary artery occlusion pressure (mmHg) | 40.6 (6.8) | 35.6 (3.9) | 0.087 |
| Systolic blood pressure (mmHg) | 116.2 (6.5) | 116.8 (5.1) | 0.184 |
| Diastolic blood pressure (mmHg) | 71.0 (8.7) | 72.3 (7.0) | 0.278 |
| Mean blood pressure (mmHg) | 86.0 (7.6) | 87.3 (6.0) | 0.482 |
HIT 4 × 4-min high -intensity interval training, MCT moderate-intensity continuous training, D diameter, FMD flow-mediated vasodilation, nFMD normalized flow-mediated vasodilation, PWV pulse wave velocity, AIx augmentation index
Intent-to-treat analysis of the effect of 12 weeks of HIT or MCT on postprandial lipemia biochemical and vascular function response after HFM ingestion
| HIT | MCT | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 min | 60 min | 120 min | 180 min | 240 min | 0 min | 60 min | 120 min | 180 min | 240 min | |
| Biochemical parameters | ||||||||||
| Total cholesterol (mg/dL) | 151.3 (21.0) | 159.0 (28.1) | 159.0 (30.2) | 163.2 (30.0) | 164.8 (20.2) | 153.1 (29.09) | 158.6 (25.1) | 165.1(25.1) | 166.8 (25.0) | 167.1 (29.4) |
| High-density lipoprotein (mg/dL) | 46.0 (14.1) | 47.3 (14.6) | 46.1 (12.7) | 48.1(16.1) | 48.7(15.9) | 42.1 (9.5) | 44.2 (11.6) | 42.5 (12.2) | 41.6 (12.6) | 40.5 (10.9) |
| Triglycerides (mg/dL) | 108.1 (35.8) | 118.7 (41.7) | 142.1 (53.7) | 177.2 (91.5) | 171.7 (84.5) | 117.7 (33.1) | 132.4 (31.1) | 196.8 (56.1) | 222.7 (68.2) | 222.5 (91.2) |
| Glucose (mg/dL) | 76.4 (11.0) | 78.8 (12.9) | 88.5 (8.8)b | 84.3 (7.8) | 86.3 (5.0 | 85.9 (6.3) | 93.6 (12.4) | 94.2 (7.8) | 93.3 (10.3) | 89.5 (10.7) |
| Vascular function parameters | ||||||||||
| Dbase, mm | 2.7 (0.4) | 2.8 (0.3) | 2.7 (0.3) | 2.7 (0.4) | 2.8 (0.3) | 3.1 (0.5) | 3.2 (0.4) | 3.2 (0.5) | 3.3 (0.5) | 3.4 (0.4) |
| FMD, % | 13.4 (4.6) | 6.3 (7.3)a | 12.3 (5.3) | 12.0 (5.8) | 10.4 (4.6) | 9.4 (4.0) | 6.1 (3.9) | 7.5 (3.1) | 7.3 (5.7) | 6.7 (4.5) |
| | 3.0 (0.3) | 2.9 (0.3) | 3.1 (0.3) | 3.0 (0.3) | 3.1 (0.4) | 3.4 (0.5) | 3.4 (0.5) | 3.4 (0.4) | 3.6 (0.5) | 3.6 (0.4) |
| | 0.3 (0.2) | 0.1 (0.1) | 0.4 (0.3) | 0.3 (0.2) | 0.3 (0.2) | 0.3 (0.2) | 0.2 (0.1) | 0.2 (0.1) | 0.3 (0.2) | 0.2 (0.1) |
| nFMD, % | 13.5 (6.3) | 13.4 (4.6) | 11.7 (6.1) | 11.8 (7.3) | 10.1 (5.1) | 8.1 (4.1) | 9.4 (4.0) | 6.5 (3.2) | 6.3 (5.2) | 5.5 (4.2) |
| PWV, m·s−1 | 6.6 (1.5) | 7.0 (1.6) | 6.6 (2.4) | 6.7 (1.2) | 6.8 (1.0) | 6.7 (0.9) | 6.5 (1.0) | 6.7 (1.0) | 6.5 (1.0) | 6.7 (1.0) |
| AIx (aortic), % | 26.3 (14.6) | 14.7 (9.4) | 15.9 (12.1) | 18.3 (12.5) | 19.1 (9.2) | 38.7 (69.0) | 7.6 (4.2) | 3.6 (16.0) | 9.5 (4.1) | 11.2 (7.0) |
| AIx (brachial), % | −22.3 (28.9) | −45.2 (18.7) | −42.7 (24.0) | −38.1 (24.8) | −36.5 (18.2) | −41.7 (16.5) | −59.3 (8.5) | −34.6 (45.0) | −55.5 (8.2) | −52.0 (13.8) |
| PP(mmHg) | 45.5 (7.7) | 49.8 (7.3) | 45.9 (8.5) | 48.5 (10.4) | 47.4 (7.4) | 45.1 (7.6) | 46.7 (6.4) | 51.0 (8.4) | 46.0 (6.6) | 48.8 (7.2) |
| SBPao (mmHg) | 107.6 (14.2) | 102.4 (7.7) | 102.6 (12.9) | 105.8 (10.2) | 106.3 (9.6) | 104.3 (7.3) | 103.6 (8.4) | 104.5 (6.1) | 105.0 (8.4) | 109.3 (9.6) |
| PPao (mmHg) | 40.6 (6.6) | 39.0 (3.4) | 36.9 (7.1) | 39.7 (6.3) | 39.3 (5.1) | 30.7 (12.9) | 33.8 (5.3) | 38.0 (6.9) | 35.0 (6.2) | 36.8 (6.1) |
| Systolic blood pressure (mmHg) | 112.5 (9.1) | 113.2 (6.4) | 111.5 (8.4) | 114.6 (7.2) | 114.3 (6.6) | 113.0 (7.6) | 116.4 (9.1) | 118.6 (6.1) | 117.0 (8.1) | 121.2 (10.8) |
| Diastolic blood pressure (mmHg) | 67.0 (10.3) | 63.4 (8.8) | 65.6 (11.4) | 66.1 (9.1) | 67.0 (8.0) | 67.8 (9.4) | 69.7 (6.2) | 66.5 (6.6) | 71.0 (11.7) | 72.4 (6.8) |
| Mean blood pressure (mmHg) | 82.0 (9.2) | 80.0 (7.4) | 80.8 (9.7) | 82.2 (7.0) | 82.9 (6.7) | 82.8 (7.8) | 85.3 (6.8) | 83.7 (5.2) | 86.2 (10.2) | 88.7 (7.7) |
Values are participant characteristics at baseline, mean (SD). HIT4 × 4-min high-intensity interval training, MCT moderate-intensity continuous training, D diameter, FMD flow-mediated vasodilation, FMDn, normalized flow-mediated vasodilation, PWV pPulse wave velocity, AIx, augmentation index, PP pulse pressure, SBPao central systolic blood pressure. PPao, pulmonary artery occlusion pressure. Whole group repeated measures ANOVA, a = 0 min vs 60 min; b = 0 min 120 min
Fig. 2Total cholesterol, triglycerides (TG) and glucose responses to PPL (left) and incremental AUC (right) after 12 weeks of HIT and MCT. Deviations from fasting were analyzed by repeated-measures ANOVA. Differences between total cholesterol, TG and glucose AUC(0–240) after 12 weeks of HIT of MCT were analyzed by two -way analysis of variance
Fig. 3FMD (%), FMDn (%) and PWV responses to PPL (left) and incremental AUC (right) after 12 weeks of HIT and MCT. Deviations from fasting were analyzed by repeated-measures ANOVA. Differences between FMD (%), FMDn (%) and PWV AUC(0–240) after 12 weeks of HIT of MCT were analyzed by two-way analysis of variance